The CloudHealth Genomics is a comprehensive genomics-based precision medicine solutions provider focused on bringing the best practices in diagnostics through innovation and high-throughput genomics to the global healthcare ecosystem. As one of China's leading genomics solution providers, we are leveraging over 40 years of combined pharma, clinical and translational science experience to advance precision medicine.
CloudHealth Genomics prides itself with a certified clinical lab and high-throughput genomics platform to generate genomic data, to understand, diagnose and provide solutions to treat disease with an emphasis of using “big data” to develop preventive medicine metrics and guidance to develop precision medicines for a healthier society with the goal of reducing disease risks and an improved quality of life.
CloudHealth Genomics, Ltd. is a comprehensive genomics-based precision medicine solutions provider focused on bringing the best practices in diagnostics through innovation (liquid biopsy) and high-throughput (HighSeq X 10) genomics to the global healthcare ecosystem. CloudHealth Genomics is part of a larger CloudHealth Medical Group ecosystem, comprising of CloudHealth Life Center, CloudHealth High-End Clinic Center, CloudHealth Big Data Center, CloudHealth Genomics Research Institute, Academician Experts Workstation. CloudHealth Club of Medical Doctors, founded in 2014 and headquartered in Shanghai, China with international branches in US and Europe.
CloudHealth Genomics prides itself with a high-throughput genomics sequencing platform and a certified clinical genetic test lab to generate genomic data, to understand, diagnose and provide solutions to treat disease with an emphasis of using “big data” to develop preventive medicine metrics and guidance to develop precision medicines for a healthier society. In addition, through our integrated health management infrastructure, a “myCloudReportTM” is generated and reviewed by our local and international team of genetic counselors. The goal of CloudHealth Genomics is reducing disease risks and an improved quality of life for both our healthy and those at risk for disease, first in China, and then globally.
National Development and Reform Commission certifies CloudHealth Genomics "Genetic Testing Center"
Practicing License of Medical Institution
International Precision Medicine Cooperation Center
CloundHealth Genome & Health Research Center
CloudHealth released the first liquid genome sequencing testing product targeted on healthy people worldwide.
Nanjing CloudHealth performed the first batch of NovaSeq high-throughput sequencing platform globally.
CloudHealth had struck strategic cooperation intention with Yangzi Group, Harvard-MIT and Broad research institution.
CloudHealth launched precision medical cooperation plan of “One Belt & One Road” in Mongolia.
CloudHealth Medical Group established
National Development and Reform Commission certifies CloudHealth Genomics "genetic testing center"
CloudHealth partners with Gongli Hospital for precision health management insurance program
CloundHealth Genome & Health Research Center established
CloudHealth Longevity & Health Research Center established
CloudHealth participates "Standardized Technology System for Big Data Processing and Utilization of Precision Medicine" led by Beijing Genomics Institute of Chinese Academy of Sciences
CloundHealth Genome & Health Research Center established
Recognition by the "Health Education Association Health Communication Branch" of Shanghai as China’s comprehensive precision medicine platform
Shanghai Economic Information Commission funds CloudHealth for Big Data Program for Chinese Population Health Program
Shanghai Zhangjiang National Innovation Demonstration Zone funds CloudHealth for “Bio-database for whole genome product trial project"
CloudHealth valued at over 1 Billion RMB
CloudHealth recieves "Outstanding Academician Expert Workstation" award
CloudHealth completes Cooperation Agreement with Shanghai International Medical Center
Cooperation with CloudHealth Genomics and Illumina
CloudHealth Clinic established
Funding for CloudHealth Molecular Medical Laboratory
Grand opening of CloudHealth Genomics Ltd. /Launch Molecular Medical Laboratory /Funding for Academician Workstation
CloudHealth X10 sequencing platform launch
Approval by Shanghai Economic Information Commission for ultra-high-throughput sequencing platform projects
CloudHealth Genomics enters International Precision Medicine Cooperation Center in China Free Trade Zone
Completed the acquisition of 13 software copyrights
CloudHealth established in Shanghai, China
Seed Funding for CloudHealth Genomics
Seed Funding for CloudHealth HiSeq X Ten Laboratory
Malaria extracellular vesicles alter vascular function via regulatory Ago2-miRNA complexes. Mantel, PY, Hjelmqvist, D, Nilsson, S, Ravel, D, Ribeiro, M, Grüring, C, Ma, S, Padmanabhan, P, Trachtenberg, AJ, Ankarklev, J, Brancucci, N, Huttenhower, C, Duraisingh, MT, Ghiran, I, Kuo, WP, Martinelli, R, Marti, M., Nature Communications, 2016 a.
Emerging technologies in extracellular vesicle-based molecular diagnostics. Jia S, Zocco D, Samuels ML, Chou MF, Chammas R, Skog J, Zarovni N, Momen-Heravi F, Kuo WP. Expert Rev Mol Diagn. 2014;14(3):307-21.
Short Course in Extracellular Vesicles – The Transition from Tissue to Liquid Biopsies. Lötvall J, Skog J, Vlassov AV, Sacido AA, Rohde E, Gere J, Kuo WP. Journal of Circulating Biomarkers. 2014, 3 (8), 1-5.
Detection Of Human c-Myc and EGFR Amplifications in Circulating Extracellular Vesicles in Mouse Tumour Models. Balaj L, Momen-Heravi F, Chen W, Sivaraman S, Zhang X, Ludwig N, Meese E, Wurdinger T, Noske D, Charest A, Hochberg FH, Vandertop P, Skog J, Kuo WP. Journal of Circulating Biomarkers. 2014, 3 (6), 1-7.
Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Zocco D, Ferruzzi P, Cappello F, Kuo WP, Fais S. Front Oncol. 2014;4:267.
Current methods for the isolation of extracellular vesicles. Momen-Heravi F, Balaj L, Alian S, Mantel PY, Halleck AE, Trachtenberg AJ, Soria CE, Oquin S, Bonebreak CM, Saracoglu E, Skog J, Kuo WP. Biol Chem. 2013, 394(10):1253-62.
Alternative methods for characterization of extracellular vesicles. Momen-Heravi F, Balaj L, Alian S, Tigges J, Toxavidis V, Ericsson M, Distel RJ, Ivanov AR, Skog J, Kuo WP. Front Physiol. 2012;3:354. Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog J, Kuo WP. Front Physiol. 2012;3:162.